— Know what they know.
Not Investment Advice

VLS.AX ASX

Vita Life Sciences Limited
1W: +0.0% 1M: -0.4% 3M: +12.7% YTD: +6.2% 1Y: +22.1% 3Y: +95.7% 5Y: +168.0%
A$2.72 ($1.89)
-0.04 (-1.45%)
 
Weekly Expected Move ±1.8%
A$3 A$3 A$3 A$3 A$3
ASX · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 57 · A$150.1M mcap · 12M float · 0.104% daily turnover

📊 Key Metrics

TTM
A$182M
Revenue
+22.9% YoY
A$20M
Net Income
+21.8% YoY
A$24M
Free Cash Flow
+34.8% YoY
63.5%
Gross Margin
17.3%
Op. Margin
11.5%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE39.2%
ROA27.6%
ROIC83.9%

Valuation

P/E13.8
P/B2.7
EV/EBITDA3.6

Leverage

Debt/Equity0.04
Current Ratio2.82
Interest Cov.49.6x

Quality Scores

Piotroski F6/9
Altman Z7.47
Beneish M-2.47

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms